Bruker Corporation
BRKRP - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$64.29B
Close$
$10.29
97.6% downside
Current Fair Value
97.6% downsideOvervalued by 97.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $64.29 Billion |
|---|---|
| Enterprise Value | $66.46 Billion |
| Annual dividend | $15.63 |
| Dividend yield | 0.35% |
| Earnings per Share | $-0.15 |
| Beta | 1.39 |
| Outstanding Shares | 152,200,000 |
Return
| Return on Equity | -2.97% |
|---|---|
| Return on Assets | -1.18% |
| Return on Invested Capital | 0.51% |
Valuation & Multiples
| P/E Ratio | -81.65 |
|---|---|
| PEG | 10.41 |
| Price to Sales | 19.2 |
| Price to Book Ratio | 28.16 |
| Enterprise Value to Revenue | 18.99 |
| Enterprise Value to EBIT | 2712.78 |
| Enterprise Value to Net Income | -934 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.98 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 29, 2026
EPS Estimate
$0.42
Consensus analyst estimateRevenue Estimate
$865.16 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$0.42
Consensus analyst estimateRevenue Estimate
$865.16 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Bruker Corp
6,000 employees
CEO: Frank Laukien
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...